While treating properties of marijuana are being studied yet and we are likely ta discover a lot more about these, there is already a way to go with help of medical cannabis when it comes to fibromyalgia. What is this disease and what options for getting better can marijuana offer?
Fibromyalgia is a condition that is characterized by pain in one’s bones, joints and soft tissues, makes people more sensitive to touch and more exposed to feeling pain caused by reasons other than the disease itself, which Center for Disease Control and Prevention calls ‘abnormal pain perception processing’. It also entails sleep problems, fatigue, memory and thinking issues, as well as considerable emotional and mental distress that, in turn, may result into a number of mental issues, e.g., anxiety or depression. Happening due to currently unknown causes, it affects approximately 2% of US adult population, what is 4 million people.
Happening among women significantly more often than in men (from twice as much according to US data to 7 times more often according to British stats), fibromyalgia is an issue of mostly middle-aged adults, though it can sometimes develop in children. Severe stress of highly traumatic event can also be a trigger for it. The disease has no known cure, so therapy includes mainly pain management and behavioral strategies aimed at general enhancing of one’s life quality. However, daily intake of painkillers seems to many a scary thing to do, especially considering the fact that fibromyalgia is not a life-threatening condition per se. So what’s the alternative?
While cannabis-derived cannabinoids have long been known for their ability to manage pain, including severe one, we can confidently say that there is a way of interest to its treating effect nowadays. Thus, Axim Biotechnologies Pharmaceutical company has developed and put on the market a gum that contains cannabinoids, MedChewRx. The product is the first of its kind, and has a potential of being a breakthrough in treating chronic pain with chewing a gum rather than taking pills of painful injections. Needless to say, the company has invested a lot into elaboration of MedChew, as it is planning to become ‘one of the world leaders in the clinical development of novel phytocannabinoid-based medicines’.
As studies have already proven effectiveness of marijuana particularly in alleviating symptoms of fibromyalgia, namely generalized pain and mood or other mental issues, the gum is likely to be one of very relevant and marketable products. Moreover, some believe that the way cannabinoids get to one’s system is even more beneficial than others as it gets in very quick through saliva, thus minimizing impact on our internal organs. Moreover, MedChew could rid the Americans of attempts to treat pain with OTC drugs and strong prescription meds (which also pose a bigger danger of getting addicted). As public and political support for medical use of marijuana in the US is getting higher and higher, the gum can be the easiest and most reliable way of easing pain for hundreds of thousands of individuals having fibromyalgia.